1. Home
  2. IROQ vs ELTX Comparison

IROQ vs ELTX Comparison

Compare IROQ & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROQ
  • ELTX
  • Stock Information
  • Founded
  • IROQ 1883
  • ELTX 2011
  • Country
  • IROQ United States
  • ELTX United States
  • Employees
  • IROQ N/A
  • ELTX N/A
  • Industry
  • IROQ Savings Institutions
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IROQ Finance
  • ELTX Health Care
  • Exchange
  • IROQ Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • IROQ 60.4M
  • ELTX 54.6M
  • IPO Year
  • IROQ 2011
  • ELTX 2021
  • Fundamental
  • Price
  • IROQ $23.30
  • ELTX $4.88
  • Analyst Decision
  • IROQ
  • ELTX Strong Buy
  • Analyst Count
  • IROQ 0
  • ELTX 3
  • Target Price
  • IROQ N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • IROQ 3.3K
  • ELTX 26.2K
  • Earning Date
  • IROQ 01-28-2025
  • ELTX 11-13-2024
  • Dividend Yield
  • IROQ 1.72%
  • ELTX N/A
  • EPS Growth
  • IROQ N/A
  • ELTX N/A
  • EPS
  • IROQ 0.62
  • ELTX N/A
  • Revenue
  • IROQ $22,441,000.00
  • ELTX N/A
  • Revenue This Year
  • IROQ N/A
  • ELTX N/A
  • Revenue Next Year
  • IROQ N/A
  • ELTX N/A
  • P/E Ratio
  • IROQ $37.34
  • ELTX N/A
  • Revenue Growth
  • IROQ N/A
  • ELTX N/A
  • 52 Week Low
  • IROQ $14.85
  • ELTX $2.96
  • 52 Week High
  • IROQ $24.00
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • IROQ 56.87
  • ELTX 46.25
  • Support Level
  • IROQ $22.04
  • ELTX $4.72
  • Resistance Level
  • IROQ $23.50
  • ELTX $5.45
  • Average True Range (ATR)
  • IROQ 0.59
  • ELTX 0.38
  • MACD
  • IROQ -0.13
  • ELTX -0.04
  • Stochastic Oscillator
  • IROQ 64.29
  • ELTX 19.33

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others, and also a variety of deposit accounts and alternative delivery channels.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: